Riken Vitamin Cuts Profit Outlook Despite Solid Balance Sheet and Higher Dividends

Riken Vitamin Co., Ltd. ( (JP:4526) ) just unveiled an update.

Riken Vitamin reported nine‑month consolidated net sales to December 31, 2025 of ¥72.5 billion, edging down 0.5% year on year, while operating profit fell 24.2% to ¥5.7 billion and ordinary profit dropped 22.3%. Profit attributable to owners of parent rose 2.0% to ¥5.9 billion, lifting earnings per share to ¥200.75, and comprehensive income increased 19.5%, reflecting stronger overall profitability despite margin pressure.

The company’s financial position remained sound, with total assets rising to ¥116.7 billion and an equity ratio of 70.2%, while it continued shareholder returns, paying a higher interim dividend and maintaining a full‑year dividend forecast of ¥110 per share. Riken Vitamin revised its full‑year earnings outlook, still projecting 4.0% sales growth to ¥96.0 billion but expecting operating profit to decline 28.9% and net profit 30.8%, signaling a more challenging profit environment even as balance sheet strength and dividend policy support investor confidence.

The most recent analyst rating on (JP:4526) stock is a Buy with a Yen3581.00 price target. To see the full list of analyst forecasts on Riken Vitamin Co., Ltd. stock, see the JP:4526 Stock Forecast page.

More about Riken Vitamin Co., Ltd.

Riken Vitamin Co., Ltd. is a Japanese food and ingredients manufacturer listed on the Tokyo Stock Exchange, operating under stock code 4526. The company focuses on processed foods, food additives and related products, serving both domestic and international markets through a diversified portfolio in the broader food industry.

Average Trading Volume: 62,070

Technical Sentiment Signal: Buy

Current Market Cap: Yen74.34B

See more insights into 4526 stock on TipRanks’ Stock Analysis page.